Historical Newspapers of South Carolina

Below is the OCR text representation for this newspapers page. It is also available as plain text as well as XML.

BRIEFLY Road work will restrict crosswalks New asphalt is scheduled to be put down on Sumter Street Tuesday and will severely re strict pedestrian crosswalks, project manager Ben Coon'rod said. A binder course of liquid as phalt eipulsion will be put down on the existing pavement first and the regular asphalt put on top of it. The binder is sticky, and will ruin the shoes of anyone who walks across it. Tracks from the binder are almost impossible to remove. Also, any cars parked on Sumter Street between Greene and Blossom streets at any time during the day will be towed, ' Coonrod said. Last week’s rainy weather has delayed completion of the project. Coonrod said that if the rain holds off, the project should be complete by Nov. 20. Now, the contractor is raising the tops of manhole covers anfl dong other work necessary to pre pare the street for repaving. Lunch donations to help fight hunger On Nov. 20, USC students can participate in the fight against hunger by giving up their lunches on their meal plan or donating $2 from their cash cards, of which Carolina Dining Services will donate a portion to Oxfam America. Students can sign up for the “Day of Fast” in University 101 classes, the Office of Community Service Programs and tables in the four main din ing halls. The sign-up tables will be in the Grand Marketplace, Gibbes Court, the Patio and Bates Cafe Wednesday until Friday and again from Monday until Nov. 14. The tables will be open from 11a.m. to 2 p.m. Director receives honor for service Ernest L. “Ernie” Ellis, di rector of USC’s Division of Law Enforcement and Safety, re ceived the Order of the Silver Crescent in a ceremony Thursday at the Carolina Plaza. The commendation repre sents the highest honor award ed for contribution of service to profession and community. “I am very taken aback, very honored,” Ellis said. “As I un derstand it, my entire staff nom inated me, and that makes it so much more valuable. I believe what we accomplish is as a team, not as individuals. But I am very flattered by what my fellow employees have done for me.” Ellis, director since 1998, has been with the divisions since 1981 and a in the law-enforce ment profession since 1970. He served the FBI one year and the South Carolina Law Enforcement Division 10 years before he joined USC. At USC, Ellis oversaw the im plementation of in-car person al computers for the USC Police Department, making it the first agency in the state with that technology. McMaster casts his vote . ^-| PHOTO BY JOHNNY HAYNES/THE GAMECOCK Henry McMaster voted Tuesday afternoon at Maxcy Gregg Park Senior Center. He ran against Steve Benjamin for South Carolina attorney general. NCAA CONTINUED FROM PAGE 1 operating principles. She said Division I schools have to undergo the certification process every 10 years. “The purpose of the process is to open the affairs of athletics to the campus community and to be able to show the benefits of athlet ics and how it can be incorporat ed within the institution’s struc ture,” she said. A peer-review team consisting of five members from various in stitutions came to USC to judge the accuracy of the university’s self-study by conducting inter views with people in the Athletics Department, including student athletes. “We’re bringing in athletes from all sports, minorities and women, and they’re going to be ^ questioned by the entire team,” Moody said. “They’re looking to see that the athletes are treated fairly and equitably and if there are any problems and concerns or so forth.” Peal said that once the peer-re view team leaves USC, it will write its own report, which will be sent to the Athletics Department for a response. All of that information will then be sent to the Committee on Athletic Certification at the NCAA, which will give the insti tution up to a year to respond to any problems the committee iden tifies. ii a sviiuui Ians 10 respond or does not try to change problems in its program, then the commit tee will decide either that the in stitution is certified with condi tions or that it is not certified. Peal said the certification pro cess “affects students in a positive manner because they’ve (the in stitution) had the opportunity to study themselves and make im provements after this thorough study.” “That impacts your student ath letes and ensures their treatment of equity for women and minori ties,” she said. Demetria Washington, a fifth year exercise science student from Fayetteville, N.C., and member of the track team that won USC’s first-ever national championship, said she thinks she is treated fair ly in the athletics program. “Personally, I don’t see any problems with the athletic teams jg at the University of South Carolina,” she said. “I’ve always been treated fairly, and my team mates have been treated fairly and, dealing with Title IX, it’s a great opportunity for women to be able to participate in sports.” Comments on this story? E-mail^ gamecockudesk@hotmail.com 1111M' | ■ BBa^n^ ril^fM'1 1-1 We re growing like crazy! Because people everywhere are discovering that RUGGED WEARHOUSE MEANS FAMOUS NAMES AT FABULOUS PRICES! Denim - Casual Fashions - Shoes - Accessories For Men - Women - Juniors - Kids Come by Friday, November 8th tor fun, refreshments, and FREE T-SHIRTS!!** Plus, register to win FREE gift certificates. Most of all, start saving up to 70% off department store prices everyday! SUMTER, SC Wesmark Plaza 1121 Broad Street, next to Sumter Mall All 42 locations are celebrating, including: FLORENCE, SC Florence Mall COLUMBIA/ HARBISON, SC Harbison Court Shopping Center (Across from Columbiana Center) 262 Harbison Boulevard i - Sat 9:30am - 9pm • Sun 1:30pm - 6pm aij0Se^G^6fllWH HfJotf** SBQ Turkey Joe™ For Special Savings, see our AD m the Coupon Section of your USC Directory! ^J^IiST^D»IVEJI>IRU^ERVICEj^CATEBIWOj^MAII. OWDtW • OlfT »HOPS | wmnwMn—ic«afcfaq.co«w (803) 7W-8MT wmIWw—He—btHt-com IContraceptive lnjection| Sirtk octroi :,outkir* aBOut just+*a*ear: medroxyprogesterone acetate injectable suspension __ DEPO-PROVERA' Contraceptive Injection (medroxyprogesterone acetate injectable suspension. USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an ntramusoJar injection (a shot) in the buttock or upper arm once every 3 months (13 weeks) To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chermci simitar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cyde DEPO-PROVERA acts by preventing your egg cess from ripening. If an egg is not released from the ovaries during your menstrual cyde. it cannot become fertilized by sperm and result in pregnancy. DEPO-PROvERA also causes changes in the lining ofypur uterus that make it less likely for pregnancy to occur. How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see *How often do I get my shot of DEPO-PROVERA Contraceptive Injection?*}- To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual penod; ONLY within the first 5 days after childbirth if not breast-feeding; and. if exclusively breast-feeding. ONLY at the sixth week alter childbirth. It is a long-term injectable contraceptive when administered at 3-month (13 week) intervals. DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate h less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends m paid on how reliably each woman uses the method. Tlie effectiveness of DEPO PROVE RA depends only on the patient returning every 3 months (13 weeks) for her next injection. Ycxr health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need in order to decide which contraceptive method is the right choice for you. The following table shows the percent of women who got pregnant while usir« different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each method exactly as it should be used) and tfie typical rate or pregnancy (wftch includes women who became pregnant because they forgot to use their birth control or because they did not fo8ow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy _In the First Year of Continuous Use__ MethodExpectedTypical ixpomcwtKAw03__ Implants (NopUrrt)0_2^02* . female ■jtenfoafon_R2;9A Male aetotenOJ0 »S Oai contraceptive (pBi) 3 Combined 0.1 Progestogen only . _05j ___ ..... - 3 fYogestasert 20 CoooerT 380A08___ Condom (without spermicide)212 Diaphragm twitfi spermicide)618 Gemot cap _8L§_ Withdr.^yal __5L®____ Periodic abstinence _il??0_ _ _____ Vaginal Sponge used before chWbirih 8 _used after cfrfeforih_9_?-8 fcjajiiflbaa_ .1 .ZZ..8S.--Si Some. Trussel et al Obsaw Gynecol 1990.76:558-567. *from Norplant* package insert , . . .. - Who should not use DEPO-PROVERA Contraceptive Injection? ^TwmenTSilduS DEPO-PROVERA. You shouldnot ^^DEPO-PROVERA if -you have any of the following conditions: * if you think you might be pregnant • f you have any vaginal bleeding without a known reason I • if you have had cancer of the breast • if you have had a stroke • if you have or have had blood dots (phlebitis) in your legs • sf you have problems with your liver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor prescribes DEPO-PROVERA It » important to tea your health-care provider if you have any of the foKowmg: • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual periods • high blood pressure • migraine headaches • asthma • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant will do so in about f 0 months after their list injection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so m about f 5 months; 3nd about 93% of those who become pregnant wSf do so in about 18 months after their last injection. The length of time you use DEPO-PROVERA has no effect on hew ions it takes you to become pregnant after you stop usng it What are the risks of using DEPO-PROVERA Contraceptive Injection? I Irregular Menstrual Bleeding ' The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle During the first year of using DEPO-PROVERA, you might have one or more of the following changes: wrewiar or unpredictable bleeding or spotting, an increase or decrease m menstrua) bleeding, or no bfeedng at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO PROVE RA, and if this happens, you should see your health-care provider right away With continued use of DEPO-PROVERA, Weeding usually decreases, and many women stop having periods completely. In clinical studies of DEPO-PROVERA. 55% of the women studied reported no menstrual Weeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries When your ovaries do not release an egg monthly, the regular monthly growth of the lining of your uterus does not occur and. therefore, the Weeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. 2. Bone Mineral Changes , Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral foss is greatest in the early years of DEPO-PROVERA use. but after that, it begins to resemble the normal rate of age-related bone mineral loss. 3. Cancer Studies of women who have used afferent forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the breast, ovary, uterus, cervix, or kver. However women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased nsk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your health-care provider 4 .Unexpected Pregnancy Because DEPO-PROVERA is such an effective contraceptive method, the nsk of accidental pregnancy for women who get their shots regularly (every 3 months [13 weeks]) is very low. Wrote there have been reports of an increased nsk of low birth weight and neonatal infant death or other health problems m infants conceived dose to the time of injection, such pregnancies are uncommon. If you think you may have become pregnant -while using DEPO-PROVERA for contraception, see your health-care provider as soon as possible. SAPergk: Reactions Some women using DEPO- PROVE RA Contraceptive Injection have reported severe and potentially life-threatening allergic reactions known as anaphylaxis and anaphylactoid reactions. Symptoms rndude the sudden onset of hives or sweHmg and itching of the skin, breathing difficulties, and a drop in blood pressure. &Other Bisks Wbmen who use hormone-based contraceptives may have an increased risk of Wood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy) White these events are rare, you should tell your health-care provider if you have any oT the problems listed in the next section. What symptoms mav signal problems while using DEPO-PROVERA Contraceptive Injection? Call your heafth-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA; ^ . • sharp chest pain, coughing up of Wood, or sudden shortness of breath (indicating a possible dot in the lung) • sudden severe headache or vomiting, dizziness or fainting, problems with you eyesight or speech, weakness, or numbness in an arm or teg (indicating a possible stroke) • severe pan or swelling m the calf (indicating a possible clot in the leg) • unusually heavy vaginal Weeding • severe pain or tenderness in the lower abdominal area • persistent pain, pus. or Weeding at the injection site What are tne possible side effects of DEPO-PROVERA Contraceptive Injection? /.Weight Gam l . , You may expeoence a weight gam while you are using DEPO-PROVERA About two thirds ot the women who used DEPO-PROVERA in diruca) trials reported a weight gam of about 5 pounds during the first year of use. You may continue to gain weight after the first year Women m one large study who used DEPO-PROVERA for 2 years gamed an average total of 8.1 PourK~J?',er those 2 years, or aporoximatefy 4 pounds per year Women who continued for 4 years ga^dan average total of 13.8 pounds over those 4 years, or approximately 35 pounds per year, women who continued for 6 years gained an average total of 165 pounds over those 6 years, or regularly every 3 months (13 weeks), then you are prcwy «** pregnant. Mowcver. it you w* that you may be pregnant, see your health-care provider. 2 Laboratory test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain Wood tests are affected by hormones such as DEPO-PROVERA. 3.Dnni Interactions Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the elfecttveoess of DEPO-PROVfcRA if the two drugs are given during ttie same time. Although DEPO-PROVERA can be passed to the nursing infant in the breast milk: no harmful effects have been found m these children. DEPO-PROVERA does not prevent the breasts from producing rmfk, so it can be used by nursing mothers. However; to minimize the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth, you should wart until 6 weeks after childbirth before you start using DEPO-PROVERA for contr aception. How often do I get my shot of DEPO-PROVERA Contraceptive Injection? The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a single intramuscular injection in die buttock or upper arm. To make sure that you are not pregnant at the time of the first injection, it is essential that the injection be given ONLY during the first 5 days of a normal menstrual period. If used following the delivery of a child, the first injection of DEPO- PROVERA MUST be given witNn 5 days after childbirth if you are not breast-feedng or 6 weeks after childbirth if you are exclusively breast feeding. If you wait longer than 3 months (13 weeks) between injections, or longer than 6 weeks after delivery, your health care provider should determine that you are not pregiant before giving you your injection of DEPO-PROVERA. Rx only CB-7-S Pharmacia & Upjohn Pharmacia & Upjohn Company Kalamazoo. Ml 498)01. USA | ____!